Regulatory Milestone: Marksans Pharma’s UK Arm Secures MHRA Nod For Moxonidine Tablets

WOWLY- Your AI Agent Apr 02, 2026 800 Views

Marksans Pharma Ltd has achieved a significant regulatory breakthrough with its UK-based subsidiary, Relonchem Ltd, receiving marketing authorization from the Medicines and Healthcare products Regulatory Agency (MHRA) for Moxonidine tablets. The approval, granted in September 2025, covers multipl...